Influenza Hospitalization Surveillance Network (FluSurv-NET)
Population-based surveillance is the collection, analysis and interpretation of data on a population in a specified area.
FluSurv-NET is a population-based surveillance system.
The Influenza Hospitalization Surveillance Network (FluSurv-NET) is a population-based surveillance system that collects data on laboratory-confirmed influenza-associated hospitalizations among children and adults through a network of acute care hospitals in 14 states.
Why FluSurv-NET Data is Important
FluSurv-NET is one of CDC’s source’s for important data on hospitalization rates associated with flu. FluSurv-NET also provides demographic and clinical information including age, sex and underlying medical conditions among persons hospitalized with flu. Data gathered are used to estimate age-specific hospitalization rates on a weekly basis and to describe characteristics of persons hospitalized with influenza illness.
FluSurv-NET Case Definition
For FluSurv-NET, a case is defined as a person who is a resident in a defined FluSurv-NET catchment area and tests positive for influenza by a laboratory test ordered by a health care professional within 14 days prior to or during hospitalization. Laboratory confirmation is defined by a positive result of a viral culture, direct or indirect fluorescent antibody staining, rapid antigen test, or molecular assay.
How FluSurv-NET Calculates Hospitalization Rates
A minimum set of data are collected on all identified cases to produce weekly hospitalization rates:
- race and ethnicity
- surveillance site
- date of hospital admission
- positive influenza test result/date
Hospitalization rates are calculated as the number of residents of a defined area who are hospitalized with a positive influenza laboratory test divided by the total population within the defined area. NCHS bridged-race population estimates are used as denominators.
FluSurv-NET coverage area includes more than 70 counties in 14 states that participate in the Emerging Infections Program (EIP) and the Influenza Hospitalization Surveillance Program (IHSP). Participating states include: California, Colorado, Connecticut, Georgia, Iowa, Maryland, Michigan, Minnesota, New Mexico, New York, Ohio, Oregon, Tennessee and Utah.
FluSurv-NET covers more than 29 million people and includes an estimated 9 percent of the U.S. population. The counties covered are located in all 10 Health and Human Services (HHS) regions. The designated FluSurv-NET surveillance area is generally similar to the U.S. population by demographics; however, the information might not be generalizable to the entire country.
Data from Iowa is not included in FluSurv-NET surveillance for the 2022-23 season.
Accessing FluSurv-NET Data
Influenza-associated hospitalization rates are reported to CDC on a weekly basis each influenza season. During seasons with influenza activity outside of the typical influenza season of October 1 through April 30, sites will be given the option to extend influenza hospitalization surveillance beyond the established surveillance period. FluSurv-NET data, including hospitalization rates for different age groups and race/ethnicity and data on patient characteristics are available on Fluview and Fluview Interactive.
FluSurv-NET hospitalization data are preliminary during each season; data presented may change as more reports are received. In particular, case counts for recent hospital admissions are subject to reporting lags. As data are received each week during the influenza season, prior case counts and rates may be updated.
FluSurv-Net Sampling Methodology for Collection of Clinical Data
Starting with the 2017-18 influenza season, FluSurv-NET implemented a sampling strategy for collection of clinical data. Clinical data were collected for a random sample of cases ≥18 years of age stratified by age and surveillance site. Random numbers were auto-generated and assigned to each case upon entry into the surveillance database. Trained surveillance staff conducted medical chart abstractions on sampled cases using a standardized case report form.
The following types of clinical data are collected for sampled cases:
- current season influenza vaccination status
- clinical (medical) history (underlying health conditions)
- clinical course (admission to intensive care unit)
- medical interventions (e.g., receipt of antiviral treatment, mechanical ventilation)
- outcomes (e.g., discharged from the hospital, in-hospital death)
How FluSurv-NET contributes to CDC’s Influenza Burden Estimates
CDC uses FluSurv-NET data in combination with other data sources to estimate annual and weekly disease burden of influenza in the United States. Estimates are made of symptomatic illnesses, medically attended illnesses, hospitalizations and deaths. Reported rates are adjusted in an attempt to correct for the under-detection of influenza. This adjustment is done by using the percent of people hospitalized with respiratory illnesses who were tested for influenza and the average sensitivity of influenza tests used in the participating FluSurv-NET hospitals. Weekly estimates of influenza burden are available during each influenza season. Annual estimates of US influenza burden and influenza burden averted by influenza vaccination are available online.
Delahoy M, Ujamaa D, Taylor C, et al. Comparison of influenza and COVID-19–associated hospitalizations among children < 18 years old in the United States—FluSurv-NET (October–April 2017–2021) and COVID-NET (October 2020–September 2021. Clinical Infectious Diseases. 2022.
Kamidani S, Garg S, Rolfes M, et al. Epidemiology, Clinical Characteristics, and Outcomes of Influenza-Associated Hospitalizations in U.S. Children Over 9 Seasons Following the 2009 H1N1 Pandemic. Clinical Infectious Diseases. 2022.
Holstein, R. Dawood FS, O’Halloran, A., et al. Characteristics of outcomes of hospitalized pregnant women with influenza, 2010-2019. A repeated cross-sectional study. Ann Intern Med. 28 December 2021.
Campbell A, Tokars J, Reynolds S, et al. Influenza Antiviral Treatment and Length of Stay. Pediatrics. 2021.
Cummings C, O’Halloran A, Azenkot T, et al. Hospital-acquired influenza in the United States, FluSurv-NET, 2011–2012 through 2018–2019. Infection Control & Hospital Epidemiology. 2021.
O’Halloran A, Holstein R, Cummings C, et al. Rates of Influenza-Associated Hospitalization, Intensive Care Unit Admission, and In-Hospital Death by Race and Ethnicity in the United States From 2009 to 2019. JAMA Network Open. 2021.
Chow E, Rolfes M, O’Halloran A, et al. Acute Cardiovascular Events Associated with Influenza in Hospitalized Adults: A Cross-sectional Study. Annals of Internal Medicine. 2020.
Chow E, Rolfes M, O’Halloran A, et al. Respiratory and Nonrespiratory Diagnoses Associated with Influenza in Hospitalized Adults. JAMA Network Open. 2020.
Chung J, Rolfes M, Flannery B, et al. Effects of Influenza Vaccination in the United States During the 2018–2019 Influenza Season. Clinical Infectious Diseases. 2020.
Owusu D, Rolfes M, Arriola Velezmoro C, et al., Rates of Severe Influenza-Associated Outcomes Among Older Adults Living With Diabetes-Influenza Hospitalization Surveillance Network (FluSurv-NET), 2012-2017, Open Forum Infectious Diseases. 2020.
Sloan C, Chandrasekhar R, Mitchel E, et al. Spatial and temporal clustering of patients hospitalized with laboratory-confirmed influenza in the United States, Epidemics. 2020.
Collins J, Campbell A, Openo K, et al. Outcomes of Immunocompromised Adults Hospitalized with Laboratory-confirmed Influenza in the United States, 2011-2015. Clinical Infectious Diseases. 2019.
Czaja C, Miller L, Alden N, et al. Age-Related Differences in Hospitalization Rates, Clinical Presentation, and Outcomes Among Older Adults Hospitalized with Influenza – U.S. Influenza Hospitalization Surveillance Network (FluSurv-NET). Open Forum Infectious Diseases. 2019.
Hughes M, Doyle J, McCaffrey K, et al. Notes from the Field: Assessment of State-Level Influenza Season Severity — Minnesota and Utah, 2017–18 Influenza Season. Morbidity and Mortality Weekly Report (MMWR). 2019.
Hughes M, Reed C, Flannery B, et al. Projected Population Benefit of Increased Effectiveness and Coverage of Influenza Vaccination on Influenza Burden in the United States. Clinical Infectious Diseases. 2019.
Rolfes M, Flannery B, Chung J, et al. Effects of Influenza Vaccination in the United States During the 2017–2018 Influenza Season. Clinical Infectious Diseases. 2019.
Budd A, Beacham L, Smith C, et al. Birth Cohort Effects in Influenza Surveillance Data: Evidence that First Influenza Infections Affects later Influenza-Associated Illness. The Journal of Infectious Diseases. 2019.
Biggerstaff M, Kniss K, Jernigan D, et al. Systematic Assessment of Multiple Routine and Near Real-Time Indicators to Classify the Severity of Influenza Seasons and Pandemics in the United States, 2003–2004 Through 2015–2016. American Journal of Epidemiology. 2018.
Collins J, Campbell A, Openo K, et al. Clinical Features and Outcomes of Immunocompromised Children Hospitalized with Laboratory-Confirmed Influenza in the United States, 2011-2015. Journal of the Pediatric Infectious Diseases Society. 2018.
Roles M, Foppa I, Garg S, et al. Annual estimates of the burden of seasonal influenza in the United States: A tool for strengthening influenza surveillance and preparedness. Influenza and Other Respiratory Diseases. 2018.
Arriola C, Garg S, Anderson E, et al. Influenza Vaccination Modifies Disease Severity Among Community-dwelling Adults Hospitalized with Influenza. Clinical Infectious Diseases. 2017.
Chandrasekhar, R, Sloan, C, Mitchel, E, et al. Social determinants of influenza hospitalization in the United States. Influenza Other Respi Viruses. 2017.
Kline, K, Hadler, JL, Yousey-Hindes, K, et al. Impact of pregnancy on observed sex disparities among adults hospitalized with laboratory-confirmed influenza, FluSurv-NET, 2010-2012. Influenza Other Respi Viruses. 2017.
Appiah G, Chaves S, Kirley P, et al. Increased Antiviral Treatment Among Hospitalized Children and Adults With Laboratory-Confirmed Influenza, 2010–2015. Clinical Infectious Diseases. 2016.
Hadler J, Yousey-Hindes K, Pérez A, et al. Influenza-Related Hospitalizations and Poverty Levels — United States, 2010–2012. [333 KB, 5 pages] Morbidity and Mortality Weekly Report (MMWR). 2016.
Su, S, Fry A, Daily K, et al. Survey of influenza and other respiratory viruses diagnostic testing in US hospitals, 2012–2013. Influenza and Other Respiratory Viruses. 2016.
Havers F, Sokolow L, Shay D, et al. Case-Control Study of Vaccine Effectiveness in Preventing Laboratory-Confirmed Influenza Hospitalizations in Older Adults, United States, 2010–2011. Clinical Infectious Diseases. 2016.
Rolfes M, Yousey-Hindes K, Meek J, et al. Respiratory Viral Testing and Influenza Antiviral Prescriptions During Hospitalization for Acute Respiratory Illnesses. Open Forum Infectious Diseases. 2016.
Oboho I, Reed C, Gargiullo P, et al., Benefit of Early Initiation of Influenza Antiviral Treatment to Pregnant Women Hospitalized With Laboratory-Confirmed Influenza. The Journal of Infectious Diseases. 2016.
Bramley AM, Chaves SS, Dawood FS, et al. Utility of Keywords from Chest Radiograph Reports for Pneumonia Surveillance Among Hospitalized Patients with Influenza: The CDC Influenza Hospitalization Surveillance Network, 2008-2009. Public Health Rep. 2016.
Millman A, Reed C, Kirley P, et al. Improving Accuracy of Influenza-Associated Hospitalization Rate Estimates. [1.53 MB, 7 pages] Emerging Infectious Diseases. 2015.
Chaves S, Lynfield R, Lindergren M, et al. The US Influenza Hospitalization Surveillance Network. Emerging Infectious Diseases. 2015.
Garg S, Jain S, Dawood, F, et al. Pneumonia among adults hospitalized with laboratory-confirmed seasonal influenza virus infection—United States, 2005–2008. BMC Infect Dis. 2015.
Arriola C, Anderson E, Baumbach J, et al., Does Influenza Vaccination Modify Influenza Severity? Data on Older Adults Hospitalized With Influenza During the 2012−2013 Season in the United States. The Journal of Infectious Diseases. 2015.
Laidler M, Thomas A, Baumbach J, et al. Statin Treatment and Mortality: Propensity Score-Matched Analyses of 2007–2008 and 2009–2010 Laboratory-Confirmed Influenza Hospitalizations, Open Forum Infectious Diseases. 2015.
Chaves S, Pérez A, Miller M, et al. Impact of Prompt Influenza Antiviral Treatment on Extended Care Needs After Influenza Hospitalization Among Community-Dwelling Older Adults. Clinical Infectious Diseases, 2015.
Jhung M, D’Mello T, Pérez A, et al. Hospital-onset influenza hospitalizations—United States, 2010-2011, American Journal of Infection Control. 2014.
Greenbaum A, Chaves S, Perez A, et al. Heavy alcohol use as a risk factor for severe outcomes among adults hospitalized with laboratory-confirmed influenza. Infection. 2014.
Dawood F, Chaves S, Pérez A, et al. Complications and Associated Bacterial Coinfections Among Children Hospitalized With Seasonal or Pandemic Influenza, United States, 2003–2010. The Journal of Infectious Diseases. 2014.
Chaves S, Perez A, Farley M, et al. The burden of influenza hospitalizations in infants from 2003 to 2012, United States. The Pediatric Infectious Disease Journal. 2014.
Dharan N, Sokolow L, Cheng P, et al. Child, household, and caregiver characteristics associated with hospitalization for influenza among children 6-59 months of age: an emerging infections program study. The Pediatric Infectious Disease Journal. 2014.
Su S, Chaves S, Perez A, et al. Comparing Clinical Characteristics Between Hospitalized Adults With Laboratory-Confirmed Influenza A and B Virus Infection. Clinical Infectious Diseases. 2014.
Reed C, Chaves S, Perez A, et al. Complications Among Adults Hospitalized With Influenza: A Comparison of Seasonal Influenza and the 2009 H1N1 Pandemic. Clinical Infectious Diseases. 2014.
Fleming-Dutra K, Taylor T, Link-Gelles R, et al. Effect of the 2009 Influenza A(H1N1) Pandemic on Invasive Pneumococcal Pneumonia. The Journal of Infectious Diseases. 2013.
Chaves S, Aragon D, Bennett N, et al. Patients Hospitalized With Laboratory-Confirmed Influenza During the 2010–2011 Influenza Season: Exploring Disease Severity by Virus Type and Subtype. The Journal of Infectious Diseases. 2013.
Thompson M, Sokolow L, Almendares O, et al. Effectiveness of Nonadjuvanted Monovalent Influenza A(H1N1)pdm09 Vaccines for Preventing Reverse Transcription Polymerase Chain Reaction–Confirmed Pandemic Influenza Hospitalizations: Case-Control Study of Children and Adults at 10 US Influenza Surveillance Network Sites. Clinical Infectious Diseases. 2013.
Vandermeer M, Thomas A, Kamimoto L, et al. Association Between Use of Statins and Mortality Among Patients Hospitalized With Laboratory-Confirmed Influenza Virus Infections: A Multistate Study. The Journal of Infectious Diseases. 2012.
Garg S, Chaves S, Pérez A, et al. Reduced Influenza Antiviral Treatment Among Children and Adults Hospitalized With Laboratory-Confirmed Influenza Infection in the Year After the 2009 Pandemic. Clinical Infectious Diseases. 2012.
Cox C, D’Mello T, Perez A, et al. Increase in Rates of Hospitalization Due to Laboratory-Confirmed Influenza Among Children and Adults During the 2009–10 Influenza Pandemic. The Journal of Infectious Diseases. 2012.
Brammer L, Blanton L, Epperson S, et al. Surveillance for Influenza during the 2009 Influenza A (H1N1) Pandemic–United States, April 2009–March 2010. Clinical Infectious Diseases. 2011.
Creanga A, Kamimoto L, Newsome K, et al. Seasonal and 2009 pandemic influenza A (H1N1) virus infection during pregnancy: a population-based study of hospitalized cases. American Journal of Obstetrics and Gynecology. 2011.
Dawood F, Kamimoto L, D’Mello T, et al. Children With Asthma Hospitalized With Seasonal or Pandemic Influenza, 2003–2009. Pediatrics. 2011.
Dee D, Bensyl D, Gindler J, et al. Racial and Ethnic Disparities in Hospitalizations and Deaths Associated with 2009 Pandemic Influenza A (H1N1) Virus Infections in the United States. Annals of Epidemiology. 2011.
Doshi S, Kamimoto L, Finelli L, et al. Description of Antiviral Treatment Among Adults Hospitalized With Influenza Before and During the 2009 Pandemic: United States, 2005–2009. The Journal of Infectious Diseases. 2011.
Fry AM, Pérez A, Finelli L, et al. Use of Intravenous Neuraminidase Inhibitors During the 2009 Pandemic: Results From Population-Based Surveillance. JAMA. 2011.
Dao C, Kamimoto L, Nowell M, et al. Adult Hospitalizations for Laboratory-Positive Influenza during the 2005–2006 through 2007–2008 Seasons in the United States. The Journal of Infectious Diseases. 2010.
Dawood F, Fiore A, Kamimoto L, et al. Burden of Seasonal Influenza Hospitalization in Children, United States, 2003 to 2008. The Journal of Pediatrics. 2010.
Dawood F, Fiore A, Kamimoto L, et al. Influenza-Associated Pneumonia in Children Hospitalized With Laboratory-Confirmed Influenza, 2003–2008. The Pediatric Infectious Disease Journal. 2010.